332 related articles for article (PubMed ID: 22926941)
1. Podocyte-specific overexpression of metallothionein mitigates diabetic complications in the glomerular filtration barrier and glomerular histoarchitecture: a transmission electron microscopy stereometric analysis.
Carlson EC; Chhoun JM; Laturnus DI; Bikash KC; Berg B; Zheng S; Epstein PN
Diabetes Metab Res Rev; 2013 Feb; 29(2):113-24. PubMed ID: 22926941
[TBL] [Abstract][Full Text] [Related]
2. Renoprotection From Diabetic Complications in OVE Transgenic Mice by Endothelial Cell Specific Overexpression of Metallothionein: A TEM Stereological Analysis.
Carlson EC; Chhoun JM; Grove BD; Laturnus DI; Zheng S; Epstein PN; Tan Y
Anat Rec (Hoboken); 2017 Mar; 300(3):560-576. PubMed ID: 27813325
[TBL] [Abstract][Full Text] [Related]
3. Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy.
Zheng S; Carlson EC; Yang L; Kralik PM; Huang Y; Epstein PN
J Am Soc Nephrol; 2008 Nov; 19(11):2077-85. PubMed ID: 18632844
[TBL] [Abstract][Full Text] [Related]
4. TEM stereometric analyses of glomeruli in aging OVE26 transgenic diabetic mice.
Teiken JM; Epstein PN; Carlson EC
Am J Nephrol; 2011; 33 Suppl 1(Suppl 1):8-14. PubMed ID: 21659729
[TBL] [Abstract][Full Text] [Related]
5. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
[TBL] [Abstract][Full Text] [Related]
6. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
Ziyadeh FN; Wolf G
Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
[TBL] [Abstract][Full Text] [Related]
8. Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis.
Lenoir O; Jasiek M; Hénique C; Guyonnet L; Hartleben B; Bork T; Chipont A; Flosseau K; Bensaada I; Schmitt A; Massé JM; Souyri M; Huber TB; Tharaux PL
Autophagy; 2015; 11(7):1130-45. PubMed ID: 26039325
[TBL] [Abstract][Full Text] [Related]
9. Empagliflozin protects glomerular endothelial cell architecture in experimental diabetes through the VEGF-A/caveolin-1/PV-1 signaling pathway.
Locatelli M; Zoja C; Conti S; Cerullo D; Corna D; Rottoli D; Zanchi C; Tomasoni S; Remuzzi G; Benigni A
J Pathol; 2022 Apr; 256(4):468-479. PubMed ID: 35000230
[TBL] [Abstract][Full Text] [Related]
10. Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis.
Wang Y; Heilig K; Saunders T; Minto A; Deb DK; Chang A; Brosius F; Monteiro C; Heilig CW
Am J Physiol Renal Physiol; 2010 Jul; 299(1):F99-F111. PubMed ID: 20375117
[TBL] [Abstract][Full Text] [Related]
11. Metallothionein over-expression in podocytes reduces adriamycin nephrotoxicity.
Yang L; Zheng S; Epstein PN
Free Radic Res; 2009 Feb; 43(2):174-82. PubMed ID: 19204870
[TBL] [Abstract][Full Text] [Related]
12. Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?
Marshall CB
Am J Physiol Renal Physiol; 2016 Nov; 311(5):F831-F843. PubMed ID: 27582102
[TBL] [Abstract][Full Text] [Related]
13. Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice.
Ku CH; White KE; Dei Cas A; Hayward A; Webster Z; Bilous R; Marshall S; Viberti G; Gnudi L
Diabetes; 2008 Oct; 57(10):2824-33. PubMed ID: 18647955
[TBL] [Abstract][Full Text] [Related]
14. Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy.
Weil EJ; Lemley KV; Mason CC; Yee B; Jones LI; Blouch K; Lovato T; Richardson M; Myers BD; Nelson RG
Kidney Int; 2012 Nov; 82(9):1010-7. PubMed ID: 22718189
[TBL] [Abstract][Full Text] [Related]
15. Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury.
Hong Q; Zhang L; Das B; Li Z; Liu B; Cai G; Chen X; Chuang PY; He JC; Lee K
Kidney Int; 2018 Jun; 93(6):1330-1343. PubMed ID: 29477240
[TBL] [Abstract][Full Text] [Related]
16. Podocyte-specific GLUT4-deficient mice have fewer and larger podocytes and are protected from diabetic nephropathy.
Guzman J; Jauregui AN; Merscher-Gomez S; Maiguel D; Muresan C; Mitrofanova A; Diez-Sampedro A; Szust J; Yoo TH; Villarreal R; Pedigo C; Molano RD; Johnson K; Kahn B; Hartleben B; Huber TB; Saha J; Burke GW; Abel ED; Brosius FC; Fornoni A
Diabetes; 2014 Feb; 63(2):701-14. PubMed ID: 24101677
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease.
Veron D; Reidy KJ; Bertuccio C; Teichman J; Villegas G; Jimenez J; Shen W; Kopp JB; Thomas DB; Tufro A
Kidney Int; 2010 Jun; 77(11):989-99. PubMed ID: 20375978
[TBL] [Abstract][Full Text] [Related]
18. Gemigliptin improves renal function and attenuates podocyte injury in mice with diabetic nephropathy.
Jung E; Kim J; Ho Kim S; Kim S; Cho MH
Eur J Pharmacol; 2015 Aug; 761():116-24. PubMed ID: 25977232
[TBL] [Abstract][Full Text] [Related]
19. Islet transplantation restores the damage of glomerulus filtration membrane in a rat model of streptozotocin-induced diabetic nephropathy.
Ziqiang X; Yunqiang H; Hongxing F; Jinjun W; Yong C
J Pak Med Assoc; 2016 Mar; 66(3):296-301. PubMed ID: 26968280
[TBL] [Abstract][Full Text] [Related]
20. Early-onset diabetic E1-DN mice develop albuminuria and glomerular injury typical of diabetic nephropathy.
Hyvönen ME; Dumont V; Tienari J; Lehtonen E; Ustinov J; Havana M; Jalanko H; Otonkoski T; Miettinen PJ; Lehtonen S
Biomed Res Int; 2015; 2015():102969. PubMed ID: 26000279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
